Company Filing History:
Years Active: 2010
Title: Matheus Puginna De Freitas: Innovator in HIV Treatment
Introduction
Matheus Puginna De Freitas is a notable inventor based in Itapira, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that aid in the treatment of HIV. His innovative work has the potential to improve the lives of many individuals affected by this virus.
Latest Patents
Matheus holds a patent for a ritonavir analogous compound that serves as a retroviral protease inhibitor. This invention describes a new ritonavir analogous compound that exhibits significantly superior activity in inhibiting HIV protease. The patent also details the usage of this compound, or its salt, ester, or prodrug forms, in medicine, especially for treating HIV infection, either alone or in combination with other anti-HIV drugs. He has 1 patent to his name.
Career Highlights
Matheus is associated with Cristalia Produtos Quimicos Farmaceuticos Ltda., where he continues to work on innovative pharmaceutical solutions. His dedication to research and development has positioned him as a key figure in the fight against HIV.
Collaborations
Matheus collaborates with talented professionals in his field, including Maria Alice Bockelmann and Simone Rosatto. Their combined expertise enhances the research and development efforts at Cristalia.
Conclusion
Matheus Puginna De Freitas is a pioneering inventor whose work in developing HIV treatment compounds showcases his commitment to improving healthcare. His contributions are vital in the ongoing battle against HIV, and his innovative spirit continues to inspire others in the pharmaceutical industry.